Atlas Trials

Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate

Clinical trial NCT01270035 · UNKNOWN

Trial details

NCT number
NCT01270035
Sponsor
Keio University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2011-01-01
Primary completion
2014-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.